Health In Tech, Inc. (HIT) P/E Ratio History
UndervaluedTrading at 52.0x vs 5Y avg 140.2x · 40th percentile · Below historical baseline · Data 2024–2025
Loading P/E history...
P/E Ratio Analysis
As of June 28, 2026, Health In Tech, Inc. (HIT) trades at a price-to-earnings ratio of 52.0x, with a stock price of $1.04 and trailing twelve-month earnings per share of $-0.01.
The current P/E is 63% below its 5-year average of 140.2x. Over the past five years, HIT's P/E has ranged from a low of 33.6x to a high of 428.8x, placing the current valuation at the 40th percentile of its historical range.
Compared to the Technology sector median P/E of 29.3x, HIT trades at a 77% premium to its sector peers. The sector includes 358 companies with P/E ratios ranging from 0.0x to 196.8x.
Relative to the broader market, HIT commands a significant premium over the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our HIT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
HIT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
HIT P/E vs Peers
Financial services and insurance software peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $7B | 66.5 | -Best | -4% | |
| $971M | 32.8 | -Best | +104%Best | |
| $388B | 32.3Lowest | -Best | -15% | |
| $133B | 75.1 | -Best | -62% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
HIT Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Dec 31 2025 | $1.59 | $0.02 | 79.5x | -43% |
| FY2025 Q3 | - | $3.21 | $0.03 | 121.6x | -13% |
| FY2025 Q2 | Jun 30 2025 | $0.88 | $0.02 | 37.6x | -73% |
| FY2025 Q1 | Mar 31 2025 | $0.66 | $0.02 | 33.6x | -76% |
| FY2024 Q4 | - | $5.36 | $0.01 | 428.8x | +206% |
Average P/E for displayed period: 140.2x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
2+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
HIT — Frequently Asked Questions
Quick answers to the most common questions about buying HIT stock.
What is HIT's P/E ratio?
Health In Tech, Inc. (HIT) trailing twelve-month P/E ratio is 52.0x, based on TTM diluted EPS of $-0.01. The 5-year average P/E is 140.2x and the historical range spans 33.6x to 428.8x.
Is HIT stock overvalued or undervalued?
HIT trades at 52.0x P/E, below its 5-year average of 140.2x. At the 40th percentile of its historical range (33.6x–428.8x), the stock is priced at a discount to its own history.
Is HIT stock expensive?
No, HIT is not expensive on a historical basis. The current P/E of 52.0x is below the 5-year average of 140.2x and sits at the 40th percentile of its valuation range.
What is HIT's historical P/E range?
Over the past 5 years, HIT's P/E ratio has ranged from 33.6x to 428.8x, with a median of 79.5x and an average of 140.2x. The current P/E of 52.0x places the stock at the 40th percentile of this range. Full historical data spans 2024–2025.
How does HIT's P/E compare to the S&P 500?
HIT trades at 52.0x P/E versus the S&P 500 median of 25.3x. The 106% premium to the market typically reflects higher expected earnings growth or quality.
How does HIT's valuation compare to Technology peers?
Health In Tech, Inc. P/E of 52.0x compares to the Technology sector median of 29.3x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is HIT's PEG ratio?
HIT PEG ratio is N/A, based on a P/E of 52.0x and EPS growth of 62.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is HIT's earnings yield?
HIT earnings yield is 1.92%, the inverse of its 52.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.